Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
General Medication Fact Sheet for Steglatro
| Field | Information |
|---|---|
| Medication Name | Steglatro |
| Generic Name | Ertugliflozin |
| Purpose | Used to treat type 2 diabetes mellitus. |
| Mechanism of Action | Inhibits the sodium-glucose co-transporter 2 (SGLT2) in the kidney, reducing glucose reabsorption and increasing glucose excretion in the urine. |
| Dosage Forms | Oral tablets |
| Available Strengths | 5 mg, 15 mg |
| Dosage Frequency | Once daily |
| Common Side Effects | Genital yeast infections, urinary tract infections, increased urination, thirst. |
| Serious Side Effects | Kidney problems, ketoacidosis, serious urinary tract infections, lower limb amputation (rare). |
| Drug Interactions | Insulin and insulin secretagogues (e.g., sulfonylureas), diuretics, drugs affecting kidney function. |
| Important Notes | Monitor kidney function and blood sugar levels regularly; stay hydrated. Report any signs of infection or unusual symptoms to your doctor. Not for use in type 1 diabetes. |
| Storage | Store at room temperature away from moisture and light. |
| Missed Dose | Take as soon as you remember unless it is almost time for your next dose. Do not double the dose. |
| Alternatives | Farxiga (dapagliflozin), Jardiance (empagliflozin), Invokana (canagliflozin), Metformin |
Steglatro Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Farxiga (dapagliflozin) | SGLT2 inhibitor | Another SGLT2 inhibitor for treating type 2 diabetes. |
| Jardiance (empagliflozin) | SGLT2 inhibitor | Another SGLT2 inhibitor with proven cardiovascular benefits. |
| Invokana (canagliflozin) | SGLT2 inhibitor | Another SGLT2 inhibitor; carries a higher risk of amputation than other SGLT2 inhibitors. |
| Metformin | Biguanide; reduces hepatic glucose production and increases insulin sensitivity. | A common first-line treatment for type 2 diabetes. |
Steglatro Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Genital yeast infections | Kidney problems |
| Urinary tract infections | Ketoacidosis |
| Increased urination | Serious urinary tract infections (urosepsis) |
| Thirst | Lower limb amputation (rare) |
| Nausea | Dehydration |
Steglatro Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| Type 2 Diabetes | 5 mg once daily | 5 mg to 15 mg once daily | Take once daily in the morning, with or without food. |
Steglatro Price With And Without Insurance
| Purchase Context | Estimated Price |
|---|---|
| With Insurance | $40 |
| Without Insurance (U.S.) | $700 |
| From CPS | $91 |
